ELMD
Electromed, Inc.
ELMD has the edge over UNH overall, supported by stronger fundamentals and stronger valuation.
UNH
UnitedHealth Group Incorporated
UNH has lower modeled downside risk, despite its lower overall score.
ELMD Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Healthy | |
| Strong |
ELMD's revenue, profitability, cash flow and balance sheet are all currently healthy.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
ELMD PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $24.97 | — |
| Cheap | 25x | $34.57 | +38% |
| Fair | 31x | $43.15 | +73% |
| Expensive | 44x | $60.28 | +141% |
Historical ranges are pointers, not guarantees.
ELMD has the edge over UNH in the historical PE scenario, which offers more potential upside but is not a forecast.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
ELMD Forward outlook
There aren't enough analyst estimates for ELMD to show an outlook.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
ELMD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $1.37 | +46% |
| Q2 2026 | $1.30 | +53% |
| Q1 2026 | $1.18 | +49% |
| Q4 2025 | $1.04 | +39% |
| Q3 2025 | $0.94 | +31% |
| Q2 2025 | $0.85 | +47% |
| Q1 2025 | $0.79 | +58% |
| Q4 2024 | $0.75 | +67% |
ELMD has the edge over UNH on earnings, with more consistent year-over-year improvement.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH's earnings per share have fallen from their peak: $17.55 over the past year, against $23.89 in early 2025.
ELMD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $18.7M | +11% |
| Q2 2026 | $19.4M | +12% |
| Q1 2026 | $18.6M | +18% |
| Q4 2025 | $18.9M | +16% |
| Q3 2025 | $16.9M | +15% |
| Q2 2025 | $17.4M | +17% |
| Q1 2025 | $15.7M | +13% |
| Q4 2024 | $16.3M | +19% |
ELMD has the edge over UNH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 19% | +2.9 points |
| Q2 2026 | 20% | +2.2 points |
| Q1 2026 | 20% | +6.6 points |
| Q4 2025 | 19% | +3.5 points |
| Q3 2025 | 16% | +2.6 points |
| Q2 2025 | 17% | +1.7 points |
| Q1 2025 | 14% | +0.4 points |
| Q4 2024 | 16% | -0.9 points |
ELMD has the edge over UNH on profitability, with a higher operating margin.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH's operating margin was 5.8% last quarter, up 2 points from the same quarter a year ago.
ELMD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $208K | +$291K |
| Q2 2026 | $2.8M | -25% |
| Q1 2026 | $3.3M | +49% |
| Q4 2025 | $2.4M | -18% |
| Q3 2025 | -$83K | -104% |
| Q2 2025 | $3.7M | -17% |
| Q1 2025 | $2.2M | +76% |
| Q4 2024 | $2.9M | -14% |
ELMD generated $9M in free cash flow over the past year, about the same as the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over ELMD on cash flow, with more consistent year-over-year improvement.
ELMD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.8% | +72.8K shares |
| 1 year | +0.9% | +79.7K shares |
| 3 years | -0.2% | -21.4K shares |
| 5 years | -1.4% | -123K shares |
| Available history | 0% | +2.3K shares |
ELMD has 9M diluted shares, up 0.9% from a year ago, despite $7M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $4.3M |
| Q2 2026 | — |
| Q1 2026 | $152,000 |
| Q4 2025 | $2.8M |
| Q3 2025 | $1M |
| Q2 2025 | $3.7M |
| Q1 2025 | $1.8M |
| Q4 2024 | — |
ELMD spent $7M buying back its own shares over the past year, up 12% from the year before.
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over ELMD on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
ELMD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.0x | Net Cash |
| Q2 2026 | -1.4x | Net Cash |
| Q1 2026 | -1.2x | Net Cash |
| Q4 2025 | -1.1x | Net Cash |
| Q3 2025 | -1.2x | Net Cash |
| Q2 2025 | -1.4x | Net Cash |
| Q1 2025 | -1.5x | Net Cash |
| Q4 2024 | -1.7x | Net Cash |
ELMD has the edge over UNH on leverage, with a lower net debt burden relative to earnings.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
ELMD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 35.8 | Neutral |
| Stochastic | 7.0 | Oversold |
ELMD's weekly RSI is 36 (neutral) and its Stochastic is 7 (oversold).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
ELMD PE vs Healthcare Sector
| Metric | ELMD | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 26x | 29% below |
| PE % | 1 | 29 | 28 pts below |
ELMD has the edge over UNH on valuation relative to its sector.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
ELMD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.1 | 7.8% below |
| 20 week MA | $33.2 | 25% below |
| 50 week MA | $30.7 | 19% below |
| 100 week MA | $27.5 | 9.3% below |
| 200 week MA | $20.9 | 20% above |
ELMD has fallen below most of its moving averages, though it's still 20% above its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over ELMD on trend strength, trading above more of its moving averages.
ELMD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $8.57 | $9.99 | +17% |
| 2021 | $9.99 | $12.7 | +27% |
| 2022 | $12.7 | $9.89 | -22% |
| 2023 | $9.89 | $10.9 | +10% |
| 2024 | $10.9 | $29.2 | +168% |
| 2025 | $29.2 | $28.5 | -2.5% |
| 2026 YTD | $28.5 | $25.0 | -12% |
ELMD has finished higher in four of the last six years. It's down 12% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over ELMD on returns for 2026, with the stronger performance.